ADAP - Adaptimmune Therapeutics PLC

QQQ $ 468.16 $ -5.41 (-1.13 %)

DIA $ 411.36 $ -1.55 (-0.38 %)

SPY $ 558.32 $ -3.26 (-0.58 %)

TLT $ 97.88 $ -0.12 (-0.12 %)

GLD $ 231.76 $ -1.64 (-0.7 %)

Previous Close

$ 1.22

Open

$ 1.21

Bid

$ 1.21 x 3,200

Ask

$ 1.22 x 1,800

Day's Range

$ 1.18 - $ 1.25

52 Week Range

$ 0.42 - $ 2.05

Volume

1,262,554

Average Volume

Market Cap

312.01M

Beta (5Y Monthly)

$ 1.84

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2024	06-30-2024	10-Q
2	05-15-2024	03-31-2024	10-Q
3	03-06-2024	12-31-2023	10-K
4	11-08-2023	09-30-2023	10-Q
5	08-09-2023	06-30-2023	10-Q
6	05-12-2023	03-31-2023	10-Q
7	03-06-2023	12-31-2022	10-K
8	11-08-2022	09-30-2022	10-Q
9	08-04-2022	06-30-2022	10-Q
10	05-09-2022	03-31-2022	10-Q
11	03-14-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-09-2021	06-30-2021	10-Q
14	05-06-2021	03-31-2021	10-Q
15	02-25-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-06-2020	06-30-2020	10-Q
18	05-14-2020	03-31-2020	10-Q
19	02-27-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-01-2019	06-30-2019	10-Q
22	05-06-2019	03-31-2019	10-Q
23	02-27-2019	12-31-2018	10-K
24	11-06-2018	09-30-2018	10-Q
25	08-02-2018	06-30-2018	10-Q
26	05-09-2018	03-31-2018	10-Q
27	03-15-2018	12-31-2017	10-K
28	11-02-2017	09-30-2017	10-Q
29	08-03-2017	06-30-2017	10-Q
30	05-10-2017	03-31-2017	10-Q
31	03-13-2017	12-31-2016	10-K
32	11-10-2016	09-30-2016	10-Q
33	08-08-2016	06-30-2016	10-Q
34	05-12-2016	03-31-2016	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Adap...
08/13/2024 18:02:05

HC Wainwright & Co. analyst Arthur He reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $4 pric...

Adaptimmune Therapeutics Q2 2024 GAAP EPS ...
08/12/2024 11:12:23

why-ainos-shares-are-trading-higher-by-around-38-here-are-20-stocks-moving-premarket

Why Ainos Shares Are Trading Higher By Aro...
08/12/2024 10:04:36

The Latest Analyst Ratings For Adaptimmune...
08/05/2024 15:00:49

HC Wainwright & Co. Reiterates Buy on Adap...
08/05/2024 09:53:18

HC Wainwright & Co. analyst Arthur He reiterates Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and maintains $4 pric...

fda-approves-adaptimmune-therapeutics-engineered-cell-therapy-as-first-for-solid-tumor-and-new-therapy-for-rare-soft-tissue-cancer-in-over-a-decade

FDA Approves Adaptimmune Therapeutics' Eng...
08/02/2024 12:46:46

FDA approves Adaptimmune Therapeutics' Tecelra for unresectable or metastatic synovial sarcoma, a rare cancer near large jo...

Trading Halt: Halt status updated at 7:00:...
08/02/2024 11:00:04

Reported Earlier, Adaptimmune's TECELRA Ga...
08/02/2024 07:17:24

Approved for advanced MAGE-A4+synovial sarcoma in adults with certain HLA types who have received prior chemotherapy TECELRA...

Trading Halt: Halted at 7:01:19 p.m. ET - ...
08/01/2024 23:01:23

HC Wainwright & Co. Initiates Coverage On ...
07/30/2024 11:07:04

HC Wainwright & Co. analyst Arthur He initiates coverage on Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy rating and...

why-sentinelone-shares-are-trading-lower-by-16-here-are-other-stocks-moving-in-fridays-mid-day-session

Why SentinelOne Shares Are Trading Lower B...
05/31/2024 17:17:02

why-adaptimmune-therapeutics-adap-stock-is-moving

Why Adaptimmune Therapeutics (ADAP) Stock ...
05/31/2024 14:28:47

Adaptimmune Therapeutics shares are trading higher by 15.8% during Friday's session. The company and Galapagos entered a cl...

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
05/31/2024 12:06:22

why-zscaler-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket

Why Zscaler Shares Are Trading Higher By A...
05/31/2024 11:44:15

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
05/30/2024 20:31:17

Galapagos And Adaptimmune Enter Clinical C...
05/30/2024 20:02:10

Adaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next gener...

Scotiabank Initiates Coverage On Adaptimmu...
05/30/2024 14:35:49

Scotiabank analyst George Farmer initiates coverage on Adaptimmune Therapeutics (NASDAQ:ADAP) with a Sector Outperform ratin...

Mizuho Maintains Buy on Adaptimmune Therap...
05/17/2024 11:31:55

Mizuho analyst Graig Suvannavejh maintains Adaptimmune Therapeutics (NASDAQ:ADAP) with a Buy and lowers the price target fro...

Adaptimmune Therapeutics Q1 2024 GAAP EPS ...
05/15/2024 12:00:07

Adaptimmune Therapeutics (NASDAQ:ADAP) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate...

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
04/19/2024 20:31:47